Advertisement

Reactions Weekly

, Volume 1695, Issue 1, pp 317–317 | Cite as

Ribavirin

Development of resistance in chronic hepatitis C: case report
Case report
  • 15 Downloads

Reference

  1. Carey I, et al. Relapse post DAA therapy: Are we too focussed on RAV and neglecting ribavirin?. Journal of Hepatology 66 (Suppl.): S511-S512 (plus poster) abstr. FRI-231, No. 1, 2017 [abstract] - United KingdomGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations